550 related articles for article (PubMed ID: 19275634)
1. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
Sagare AP; Deane R; Zlokovic BV
Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
4. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
Bhargavan B; Woollard SM; McMillan JE; Kanmogne GD
Mol Neurodegener; 2021 Nov; 16(1):78. PubMed ID: 34809709
[TBL] [Abstract][Full Text] [Related]
5. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.
Osgood D; Miller MC; Messier AA; Gonzalez L; Silverberg GD
Neurobiol Aging; 2017 Sep; 57():178-185. PubMed ID: 28654861
[TBL] [Abstract][Full Text] [Related]
6. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin.
András IE; Eum SY; Huang W; Zhong Y; Hennig B; Toborek M
Mol Cell Neurosci; 2010 Feb; 43(2):232-43. PubMed ID: 19944163
[TBL] [Abstract][Full Text] [Related]
10. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.
Shibata M; Yamada S; Kumar SR; Calero M; Bading J; Frangione B; Holtzman DM; Miller CA; Strickland DK; Ghiso J; Zlokovic BV
J Clin Invest; 2000 Dec; 106(12):1489-99. PubMed ID: 11120756
[TBL] [Abstract][Full Text] [Related]
11. Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody.
Schlein E; Andersson KG; Dallas T; Syvänen S; Sehlin D
MAbs; 2024; 16(1):2339337. PubMed ID: 38634473
[TBL] [Abstract][Full Text] [Related]
12. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
[TBL] [Abstract][Full Text] [Related]
14. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
[TBL] [Abstract][Full Text] [Related]
15. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.
Zhang L; Postina R; Wang Y
Cell Mol Life Sci; 2009 Dec; 66(24):3923-35. PubMed ID: 19672558
[TBL] [Abstract][Full Text] [Related]
16. QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE.
Dou J; Zhang X; Hu C; Gao Y; Zhao Y; Hei M; Wang Z; Guo N; Zhu H
Exp Gerontol; 2024 Jun; 190():112422. PubMed ID: 38599502
[TBL] [Abstract][Full Text] [Related]
17. Effect of β-amyloid on blood-brain barrier properties and function.
Petrushanko IY; Mitkevich VA; Makarov AA
Biophys Rev; 2023 Apr; 15(2):183-197. PubMed ID: 37124923
[TBL] [Abstract][Full Text] [Related]
18. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.
Crane A; Brubaker WD; Johansson JU; Trigunaite A; Ceballos J; Bradt B; Glavis-Bloom C; Wallace TL; Tenner AJ; Rogers J
Alzheimers Dement; 2018 Feb; 14(2):243-252. PubMed ID: 28755839
[TBL] [Abstract][Full Text] [Related]
19. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.
Liu LL; Shen X; Gu H; Zhao G; Du Y; Zheng W
Fluids Barriers CNS; 2023 May; 20(1):32. PubMed ID: 37122007
[TBL] [Abstract][Full Text] [Related]
20. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
